---
id: FC-186
type: Flashcard
created: 2025-08-08 10:00:27.592160
tags:
- Flashcard
- question
- cardiovascular
topic: cardiovascular
answer: D
related_articles:
- title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  path: 2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
  similarity: 0.778
  link: '[[2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists|In
    Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse
    Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.]]'
- title: SGLT-2 Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest,
    Even in Patients With Established Heart Disease.
  path: 2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi.md
  similarity: 0.75
  link: '[[2025/2025-01-sglt-2-inhibitors-reduce-cardiovascular-mortality-but-benefi|SGLT-2
    Inhibitors Reduce Cardiovascular Mortality, but Benefit Is Modest, Even in Patients
    With Established Heart Disease.]]'
- title: PREVENT Equations for Assessing Cardiovascular Risk.
  path: 2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk.md
  similarity: 0.75
  link: '[[2024/2024-09-prevent-equations-for-assessing-cardiovascular-risk|PREVENT
    Equations for Assessing Cardiovascular Risk.]]'
- title: 'Management of Heart Failure: Updated Guidelines From the AHA/ACC.'
  path: 2023/2023-09-management-of-heart-failure-updated-guidelines-from-the-aha.md
  similarity: 0.625
  link: '[[2023/2023-09-management-of-heart-failure-updated-guidelines-from-the-aha|Management
    of Heart Failure: Updated Guidelines From the AHA/ACC.]]'
- title: Vericiguat (Verquvo) for the Treatment of Heart Failure.
  path: 2022/2022-11-vericiguat-verquvo-for-the-treatment-of-heart-failure.md
  similarity: 0.625
  link: '[[2022/2022-11-vericiguat-verquvo-for-the-treatment-of-heart-failure|Vericiguat
    (Verquvo) for the Treatment of Heart Failure.]]'
topics:
- Cardiology
- Emergency Medicine
related_articles_2023_2025:
- title: editorial cardiovascular disparities south asian people
  path: 2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people.md
  similarity: 0.308
  link: '[[2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people|editorial
    cardiovascular disparities south asian people]]'
last_updated: '2025-08-10T20:25:11.201559'
---

# Flashcard FC-186

## Question

which one of the followingstatementsaboutthe PREVENTequationsforassessingcardiovascularrisk is correct? Theyweredevelopedfromamultinationalregistry. Theyincludesocialdeprivationestimatedbyapatientshouseholdincome. Theypredictthe20-yearriskofacerebrovascularevent. Theypredictthe10-yearriskofheartfailureandatheroscleroticcardiovasculardisease(ASCVD). @ Back

## Answer

**D**

## Explanation

The PREVENTequationswerederivedfromaregistrythatincludedmorethan6 million U. S.adults. Socialdeprivationisestimatedusingthepatientszipcode. Primaryoutcomespredictedbytheriskscore are10-and30-yearriskof ASCVDandheartfailure. e

## References

- AAFPQuestion Bank-Pythonsimplecapture.

